{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "38182705",
  "DateCompleted": {
    "Year": "2024",
    "Month": "01",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2024",
    "Month": "01",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2024",
        "Month": "01",
        "Day": "05"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "645",
      "10.1038/s41598-023-50856-0"
    ],
    "Journal": {
      "ISSN": "2045-2322",
      "JournalIssue": {
        "Volume": "14",
        "Issue": "1",
        "PubDate": {
          "Year": "2024",
          "Month": "Jan",
          "Day": "05"
        }
      },
      "Title": "Scientific reports",
      "ISOAbbreviation": "Sci Rep"
    },
    "ArticleTitle": "Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022-August 2023.",
    "Pagination": {
      "StartPage": "645",
      "MedlinePgn": "645"
    },
    "Abstract": {
      "AbstractText": [
        "The growing occurrence of novel recombinants, such as XBB.1.16, has emerged and become predominant, raising concerns about the impact of genomic recombination on the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study investigated the molecular epidemiological trends and evolution of the Omicron XBB.1.16 epidemic in Bangkok between December 2022 and August 2023. Partial spike and complete genome sequencing of SARS-CoV-2 samples collected from collaborating hospitals were performed. The analysis of 491 partial spike sequences identified 15 distinct lineages, with XBB.1.16 dominating the lineages beginning in March 2023. Phylogenetic analysis revealed at least four distinct XBB.1.16 lineages, suggesting multiple independent introductions into Bangkok. The estimated emergence of XBB.1.16 occurred approximately in January 2022, with an evolutionary rate of 0.79\u2009\u00d7\u200910<sup>-3</sup> substitutions per site per year. Monitoring the genomic epidemiology and evolution of XBB.1.16 is vital for the early detection of new strains or emerging variants, which may guide vaccine design and the inclusion of new vaccine strains."
      ],
      "CopyrightInformation": "\u00a9 2024. The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."
          }
        ],
        "LastName": "Puenpa",
        "ForeName": "Jiratchaya",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."
          }
        ],
        "LastName": "Chansaenroj",
        "ForeName": "Jira",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand."
          }
        ],
        "LastName": "Suwannakarn",
        "ForeName": "Kamol",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Yong.P@chula.ac.th."
          },
          {
            "Identifier": [],
            "Affiliation": "FRS(T), The Royal Society of Thailand, Sanam Sueapa, Dusit, Bangkok, Thailand. Yong.P@chula.ac.th."
          }
        ],
        "LastName": "Poovorawan",
        "ForeName": "Yong",
        "Initials": "Y"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Sci Rep",
    "NlmUniqueID": "101563288",
    "ISSNLinking": "2045-2322"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Vaccines"
    }
  ],
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Thailand"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Phylogeny"
    },
    {
      "QualifierName": [
        "epidemiology",
        "genetics"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genomics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Vaccines"
    }
  ],
  "CoiStatement": "The authors declare no competing interests."
}